company background image
874

Guangzhou Baiyunshan Pharmaceutical Holdings SEHK:874 Stock Report

Last Price

HK$19.38

Market Cap

HK$49.5b

7D

-1.5%

1Y

-7.0%

Updated

18 Aug, 2022

Data

Company Financials +
874 fundamental analysis
Snowflake Score
Valuation6/6
Future Growth0/6
Past Performance5/6
Financial Health5/6
Dividends4/6

874 Stock Overview

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People’s Republic of China and internationally.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Guangzhou Baiyunshan Pharmaceutical Holdings
Historical stock prices
Current Share PriceHK$19.38
52 Week HighHK$24.00
52 Week LowHK$18.02
Beta0.61
1 Month Change-8.37%
3 Month Change-5.69%
1 Year Change-7.05%
3 Year Change-40.82%
5 Year Change-4.77%
Change since IPO1,346.27%

Recent News & Updates

Aug 02
Does Guangzhou Baiyunshan Pharmaceutical Holdings (HKG:874) Have A Healthy Balance Sheet?

Does Guangzhou Baiyunshan Pharmaceutical Holdings (HKG:874) Have A Healthy Balance Sheet?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

May 30
Guangzhou Baiyunshan Pharmaceutical Holdings (HKG:874) Is Paying Out A Larger Dividend Than Last Year

Guangzhou Baiyunshan Pharmaceutical Holdings (HKG:874) Is Paying Out A Larger Dividend Than Last Year

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited ( HKG:874 ) will increase its dividend on the 14th of July...

Apr 29
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's (HKG:874) Intrinsic Value Is Potentially 83% Above Its Share Price

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's (HKG:874) Intrinsic Value Is Potentially 83% Above Its Share Price

Does the April share price for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited ( HKG:874 ) reflect what...

Shareholder Returns

874HK PharmaceuticalsHK Market
7D-1.5%-1.9%1.5%
1Y-7.0%-36.7%-20.8%

Return vs Industry: 874 exceeded the Hong Kong Pharmaceuticals industry which returned -36.7% over the past year.

Return vs Market: 874 exceeded the Hong Kong Market which returned -20.8% over the past year.

Price Volatility

Is 874's price volatile compared to industry and market?
874 volatility
874 Average Weekly Movement4.7%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.5%
10% most volatile stocks in HK Market12.8%
10% least volatile stocks in HK Market3.2%

Stable Share Price: 874 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: 874's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199725,437Hong Lihttps://www.gybys.com.cn

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People’s Republic of China and internationally. The company operates through four segments: Great Southern TCM, Great Commerce, Great Health, and Others. It is also involved in the wholesale, retail, import, and export of Western and Chinese medicines, and medical apparatus and instruments; and research and development, production, and sale of beverages, food, healthcare products, pre-packaging food, dairy products, tablets, capsules, lozenges, injections, tortoise herb jelly, etc. In addition, the company invests in health industry, such as medical care, health management, health preservation, elderly care, etc.; and provides commercial and advertising services.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Fundamentals Summary

How do Guangzhou Baiyunshan Pharmaceutical Holdings's earnings and revenue compare to its market cap?
874 fundamental statistics
Market CapHK$49.55b
Earnings (TTM)HK$4.51b
Revenue (TTM)HK$80.40b

7.0x

P/E Ratio

0.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
874 income statement (TTM)
RevenueCN¥69.51b
Cost of RevenueCN¥55.98b
Gross ProfitCN¥13.52b
Other ExpensesCN¥9.62b
EarningsCN¥3.90b

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

Aug 19, 2022

Earnings per share (EPS)2.40
Gross Margin19.45%
Net Profit Margin5.61%
Debt/Equity Ratio32.1%

How did 874 perform over the long term?

See historical performance and comparison

Dividends

4.1%

Current Dividend Yield

29%

Payout Ratio